HPTN Publications

Kilmarx PH, Paxton L, Van Damme L, Rees h, Ramjee G, Laga M, Mâsse B . Need for a true placebo for vaginal microbicide efficacy trials. Lancet. 2003, 361: 785-786

Kim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C . Effect of Acyclovir on HIV 1 Set Point among Herpes Simplex Virus Type 2 Seropositive Persons during Early HIV 1 Infection. J Infect Dis. 2010, 202: 734-8

Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou SS, Baglyos L, Gurunathan S, Zwerski S, Jackson JB, Guay L . Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa. J Acquir Immune Defic Syn. 2013, 63: 1-8

Kirkpatrick AR, Patel EU, Celum CL, Moore RD, Blankson JN, Mehta SH, Kirk GD, Margolick JB, Quinn TC, Eshleman SH, Laeyendecker O . Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses. 2016, 32: 756-62

Kirkpatrick AR, Unsal AB, Blankson JN, Moore RD, Quinn TC, Hadigan C, Laeyendecker O . Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults. Pediatr Infect Dis J. 2017, 36: 1064-1066

Klevytska AM, Mracna MR, Guay L, Becker-Pergola G, Furtado M, Zhang, L, Jackson JB, and Eshleman SH . Analysis of length variation in the V1-V2 region of env in non-subtype B HIV-1 from Uganda. AIDS Res Hum Retroviruses. 2002, 18: 791-6

Klinkenberg E, Floyd S, Shanaube K, Mureithi L, Gachie T, de Haas P, Kosloff B, Dodd PJ, Ruperez M, Wapamesa C, Burnett JM, Kalisvaart N, Kasese N, Vermaak R, Schaap A, Fidler S, Hayes R, Ayles H; TREATS study team . Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS). PLoS Med. 2023, 20: e1004278

Klock E, Wilson E, Fernandez RE, Piwowar-Manning E, Moore A, Kosloff B, Bwalya J, Bell-Mandla N, James A, Ayles H, Bock P, Donnell D, Fidler S, Hayes R, Eshleman SH, Laeyendecker O, HPTN 071 (PopART) study team . Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.. J Int AIDS Soc. 2021, 24: e25830